Companies / Financials
MET
MetLife
Life & Health Insurance
Life & Health InsuranceAnalysis in progress
In progress
We are decoding this company's strategy and relationships
New analyses are published every weekday. Founding members get them first.
Business at a glance
Operating-health scores describe reported fundamentals on a 0–100 scale. They are not a rating of the stock. How they work
Operating health78
Growth48
Profitability100
Cash generationn/a
Balance sheetn/a
Dilution control87
Key ratios and five-year financials
Latest quarter revenue YoY (2026-09-30)17.2%Revenue growth (FY)8.5%Revenue CAGR (3y)4.9%Gross margin—Operating margin251.9%Net margin138.7%Free cash flow margin701.6%R&D / revenue—Stock comp / revenue5.4%Net debt / operating cash flow-1.27xCurrent ratio—Diluted share count change-5.3%
| Fiscal year ending | FY 2021-12 | FY 2022-12 | FY 2023-12 | FY 2024-12 | FY 2025-12 |
|---|---|---|---|---|---|
| Revenue | $2.1B | $2.1B | $2.2B | $2.2B | $2.4B |
| Operating income | — | $6.0B | $5.7B | $6.0B | $6.1B |
| Net income | $6.9B | $5.3B | $1.6B | $4.4B | $3.4B |
| Operating cash flow | $12.3B | $13.0B | $13.7B | $14.6B | $17.1B |
| Free cash flow | $12.3B | $13.0B | $13.7B | $14.6B | $17.1B |
| Stock-based comp | $173M | $184M | $171M | $168M | $131M |
| Buybacks | $4.3B | $3.3B | $3.1B | $3.2B | $2.9B |
| Dividends | $1.6B | $1.6B | $1.6B | $1.5B | $1.5B |
| Cash | $20.0B | $20.2B | $20.6B | $20.1B | $22.0B |
| Total debt | $341M | $175M | $119M | $465M | $355M |
| Equity | $67.5B | $29.9B | $30.0B | $27.4B | $28.4B |
StratGraph publishes general, impersonal research about public companies based on public filings. It is not investment advice, not a recommendation to buy, sell or hold any security, and not tailored to any reader's circumstances. Content may contain errors and may be partly generated with AI tools; verify against the original filings, which are linked. Authors may not trade securities discussed within the window set by our trading policy. Full disclaimer.